Page last updated: 2024-08-25

chitosan and Neutropenia

chitosan has been researched along with Neutropenia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bakker-Woudenberg, IAJM; Refos, JM; Ten Kate, MT; van de Sande, WWJ; Verbrugh, HA; Vonk, AG1
Chen, CT; Chou, YC; Chuang, EY; Lin, KJ; Lin, PY; Mi, FL; Su, FY; Sung, HW; Wey, SP; Yen, TC1
Arfan, M; Khan, JA; Latif, U; Mushtaq, S; Rabbani, F; Yameen, MA1

Other Studies

3 other study(ies) available for chitosan and Neutropenia

ArticleYear
Chitinase Induction Prior to Caspofungin Treatment of Experimental Invasive Aspergillosis in Neutropenic Rats Does Not Enhance Survival.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:1

    Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Chitinases; Chitosan; Disease Models, Animal; Female; Invasive Pulmonary Aspergillosis; Lung; Microbial Sensitivity Tests; Molecular Weight; Neutropenia; Rats

2018
Treatment of chemotherapy-induced neutropenia in a rat model by using multiple daily doses of oral administration of G-CSF-containing nanoparticles.
    Biomaterials, 2014, Volume: 35, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Chitosan; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Glucose; Granulocyte Colony-Stimulating Factor; Hydrogen-Ion Concentration; Intestinal Mucosa; Intestines; Nanoparticles; Neutropenia; Particle Size; Pentetic Acid; Polyglutamic Acid; Positron-Emission Tomography; Proteolysis; Rats; Rats, Wistar; Static Electricity; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2014
Biocompatible biodegradable polymeric antibacterial nanoparticles for enhancing the effects of a third-generation cephalosporin against resistant bacteria.
    Journal of medical microbiology, 2017, Volume: 66, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Ceftriaxone; Chitosan; Disease Models, Animal; Drug Synergism; Escherichia coli; Escherichia coli Infections; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Microbial Viability; Nanoparticles; Neutropenia; Staphylococcal Infections

2017